Published in J Am Soc Nephrol on December 01, 1998
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Rate of kidney function decline associates with mortality. J Am Soc Nephrol (2010) 2.76
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis. Clin J Am Soc Nephrol (2011) 1.19
Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) study. Soc Sci Med (2008) 1.10
Immune dysfunction in uremia—an update. Toxins (Basel) (2012) 1.03
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease. Clin J Am Soc Nephrol (2010) 1.01
Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients. J Korean Med Sci (2009) 0.97
Inflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: a cross-sectional study. BMC Res Notes (2012) 0.86
Accuracy and limitations of the diagnosis of malnutrition in dialysis patients. Semin Dial (2012) 0.83
Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors. Hypertension (2016) 0.83
Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease. Curr Cardiol Rev (2015) 0.79
Serum lipid profile constituents as markers of cardiovascular morbidity in patients on chronic hemodialysis. Biomark Insights (2007) 0.79
Antihypertensive medication use and change in kidney function in elderly adults: a marginal structural model analysis. Int J Biostat (2011) 0.78
Change in cardiovascular risk factors with progression of kidney disease. Am J Nephrol (2008) 0.77
Pretransplant malnutrition, inflammation, and atherosclerosis affect cardiovascular outcomes after kidney transplantation. BMC Nephrol (2015) 0.77
The lipid story in chronic kidney disease: a long story with a happy end? Int Urol Nephrol (2013) 0.76
Chapter 2: Pharmacological cholesterol-lowering treatment in adults. Kidney Int Suppl (2011) (2013) 0.75
Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations. Int J Cardiol (2017) 0.75
Association of vascular access flow with short-term and long-term mortality in chronic haemodialysis patients: a retrospective cohort study. BMJ Open (2017) 0.75
Blood Pressure Before Initiation of Maintenance Dialysis and Subsequent Mortality. Am J Kidney Dis (2017) 0.75
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18
From disorder to order in marching locusts. Science (2006) 7.99
Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med (2001) 5.48
Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA (1998) 5.37
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75
Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med (1994) 4.64
"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int (1998) 3.53
Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int (2006) 3.36
Early predictors of career achievement in academic medicine. JAMA (1992) 3.35
Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA (1997) 3.27
Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol (2000) 3.27
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr (2001) 3.12
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA (1992) 3.01
Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension (2000) 3.01
Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med (2000) 3.01
Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol (1997) 2.99
Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int (2000) 2.85
Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med (1991) 2.74
Diabetes mellitus, race, and socioeconomic status. A population-based study. Ann Epidemiol (1996) 2.71
Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2001) 2.69
Intercenter variance in clinical trials of head trauma--experience of the National Acute Brain Injury Study: Hypothermia. J Neurosurg (2001) 2.39
Body mass index in young men and the risk of subsequent knee and hip osteoarthritis. Am J Med (1999) 2.38
A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study. JAMA (1993) 2.25
End-stage renal disease attributable to diabetes mellitus. Ann Intern Med (1994) 2.16
Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Intern Med (1995) 2.12
Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med (1998) 2.07
Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA (1997) 2.06
Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis (2001) 2.05
Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol (2001) 2.03
Migration, blood pressure pattern, and hypertension: the Yi Migrant Study. Am J Epidemiol (1991) 1.94
The pig as a model for human nutrition. Annu Rev Nutr (1987) 1.87
Incidence and risk factors for gout in white men. JAMA (1991) 1.82
Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med (1991) 1.79
End-stage renal disease in US minority groups. Am J Kidney Dis (1992) 1.74
Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med (1993) 1.65
Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol (1998) 1.54
Physician, heal Thyself? Regular source of care and use of preventive health services among physicians. Arch Intern Med (2000) 1.54
A decision analysis of mandatory compared with voluntary HIV testing in pregnant women. Ann Intern Med (1998) 1.53
Left ventricular hypertrophy and skin color among American blacks. Am J Epidemiol (1991) 1.52
Body weight patterns from 20 to 49 years of age and subsequent risk for diabetes mellitus: the Johns Hopkins Precursors Study. Arch Intern Med (1999) 1.49
Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum (1995) 1.43
Kidney transplantation from living unrelated donors. Ann Intern Med (1992) 1.41
The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens (2000) 1.39
The effects of aerobic exercise and T'ai Chi on blood pressure in older people: results of a randomized trial. J Am Geriatr Soc (1999) 1.36
Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. Arch Intern Med (1997) 1.30
Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med (1993) 1.26
Influence of environmental quality on pollen competitive ability in wild radish. Science (1990) 1.20
Variation in utilization of procedures for treatment of peripheral arterial disease. A look at patient characteristics. Arch Intern Med (1993) 1.19
Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence. Hypertension (1989) 1.15
Medical specialty and the incidence of divorce. N Engl J Med (1997) 1.11
Projections of hypertension-related renal disease in middle-aged residents of the United States. JAMA (1993) 1.11
An infinite number of laminagrams from a finite number of radiographs. Radiology (1971) 1.09
Cause of death in patients with end-stage renal disease: death certificates vs registry reports. Am J Public Health (1993) 1.08
Initiation of voiding. Br J Urol (1970) 1.07
The psychosocial work environment of physicians. The impact of demands and resources on job dissatisfaction and psychiatric distress in a longitudinal study of Johns Hopkins Medical School graduates. J Occup Environ Med (1995) 1.07
TECHNIQUE AND INTERPRETATION OF LOWER EXTREMITY VENOGRAMS. Calif Med (1946) 1.07
HDL cholesterol and mortality in Finnish men with special reference to alcohol intake. Circulation (1994) 1.07
IRB review and consent in human tissue research. Science (1999) 1.06
The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension (1999) 1.05
Histology of healing split-thickness, full-thickness autogenous skin grafts and donor sites. Arch Surg (1965) 1.05
Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. Am J Epidemiol (2001) 1.05
Relation between gender and vascular access complications in hemodialysis patients. Am J Kidney Dis (2000) 1.04
Plasma insulin levels and incidence of hypertension in African Americans and whites. Arch Intern Med (1999) 1.04
Guilt, shame, and symptoms in children. Dev Psychol (1999) 1.04
Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors. Stroke (1995) 1.02
Fumaric and citric acids as feed additives in starter pig diets: effect on performance and nutrient balance. J Anim Sci (1988) 1.02
Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study. Circulation (2000) 1.02
Exercise and depression in midlife: a prospective study. Am J Public Health (1997) 1.02
Emetic activity of the trichothecene 15-acetyldeoxynivalenol in swine. Food Chem Toxicol (1987) 1.01
Diagnosis of hypertensive end-stage renal disease: effect of patient's race. Am J Epidemiol (1995) 1.01
Risk of end-stage renal disease associated with alcohol consumption. Am J Epidemiol (1999) 1.01
Variability among sources and laboratories in nutrient analyses of corn and soybean meal. NCR-42 Committee on Swine Nutrition. North Central Regional-42. J Anim Sci (1999) 1.00
Diagnostic procedures and cinefluoroscopy in vesico-ureteral reflux. Br J Urol (1966) 0.99
The renin-angiotensin system and blood pressure: differences between blacks and whites. Am J Hypertens (1999) 0.99
Relationship between systemic markers of inflammation and serum beta-carotene levels. Arch Intern Med (2001) 0.99
Effect of migration and related environmental changes on serum lipid levels in southwestern Chinese men. Am J Epidemiol (1996) 0.99
Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers. Kidney Int (2001) 0.98
Recreational drug use: a neglected risk factor for end-stage renal disease. Am J Kidney Dis (2001) 0.97
The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution. Infect Control Hosp Epidemiol (1999) 0.97
Alcohol: role in the development of hypertension and end-stage renal disease. Curr Opin Nephrol Hypertens (2001) 0.96
Temperament as a potential predictor of mortality: evidence from a 41-year prospective study. J Behav Med (1994) 0.96
Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation (1994) 0.95
Combined gas (CO2) endarterectomy and vein bypass graft for patients with coronary artery disease. Ann Thorac Surg (1970) 0.95
Low birth weight is associated with chronic kidney disease only in men. Kidney Int (2007) 0.95
Body mass and blood pressure in a lean population in southwestern China. Am J Epidemiol (1994) 0.93
Effects of zeolite a or clinoptilolite in diets of growing swine. J Anim Sci (1984) 0.93
Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans. J Med Genet (2006) 0.93
Kidney damage in 'benign' essential hypertension. Curr Opin Nephrol Hypertens (1997) 0.93
The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence. J Hum Hypertens (1996) 0.92
Bladder cancer risk among laundry workers, dry cleaners, and others in chemically-related occupations. J Occup Med (1985) 0.92
Supplemental microbial phytase improves bioavailability of dietary zinc to weanling pigs. J Nutr (1993) 0.92
National surveillance of dialysis-associated diseases in the United States, 1997. Semin Dial (2000) 0.92
A copper deficiency in neonatal pigs induced by a high zinc maternal diet. J Nutr (1983) 0.91
Magnesium and blood pressure: review of the epidemiologic and clinical trial experience. Am J Cardiol (1989) 0.91
Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention. Ann Epidemiol (1992) 0.90
Vein bypass graft and carbon dioxide gas endarterectomy for coronary artery occlusive disease. JAMA (1969) 0.90
Oats and buckwheat intakes and cardiovascular disease risk factors in an ethnic minority of China. Am J Clin Nutr (1995) 0.90
The effects of antibiotics in the weanling pig diet on growth and the excretion of volatile phenolic and aromatic bacterial metabolites. Am J Clin Nutr (1982) 0.90
Impact of pill organizers and blister packs on adherence to pill taking in two vitamin supplementation trials. Am J Epidemiol (2000) 0.90